Literature DB >> 8511919

Occupational risk to surgeons of unrecognized HIV infection in a low-prevalence area.

S Evrard1, P Meyer, K van Haaften, D Christmann, J Marescaux.   

Abstract

Data are available on the occupational risk to surgeons of the human immunodeficiency virus (HIV) for areas of high HIV prevalence but not for low-risk areas and particularly for unrecognized HIV infection. The 40-year cumulative occupational risk to surgeons caring for patients with unknown HIV serologies in a low-prevalence area was estimated. From May 1989 to May 1991, 4119 consecutive patients with unknown HIV status, hospitalized in our department, were proposed for testing; 100% complied. Acquired immunodeficiency syndrome (AIDS) patients and known seropositive patients operated on during this period were excluded from the study. The prevalence of unknown HIV infection was 0.07%. Taking into account the rate of parenteral injuries, the rate of contamination after an infected parenteral injury, and the total number of operations performed during a 40-year career, we estimated the cumulative risk of unknown HIV infection in our area to be 1%. This risk must be added to those of caring for known infected patients. In high-risk areas (cumulative risk 10%), a high standard of infection control is required for every surgical procedure, even if it is expensive or of doubtful efficacy. It is unrealistic to apply this standard in a low-risk area. HIV testing with informed consent of the patient is an imperfect guard against infection but has the advantage of alerting the surgeon to the risk of contamination on a case-by-case basis; it also offers the seropositive patient the best possibility for a longer life expectancy.

Entities:  

Mesh:

Year:  1993        PMID: 8511919     DOI: 10.1007/BF01658932

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Frequency of puncture injuries in surgeons and estimated risk of HIV infection.

Authors:  A B Lowenfels; G P Wormser; R Jain
Journal:  Arch Surg       Date:  1989-11

2.  Attitudes and experiences of human immunodeficiency virus-positive patients to surgery and surgeons.

Authors:  S K Gill; M Emberton; H J Scott
Journal:  Br J Surg       Date:  1992-04       Impact factor: 6.939

3.  Risk to surgeons: a survey of accidental injuries during operations.

Authors:  S A Hussain; A B Latif; A A Choudhary
Journal:  Br J Surg       Date:  1988-04       Impact factor: 6.939

4.  The importance to the practicing surgeon of knowing the human immunodeficiency virus status of patients.

Authors:  T R Gadacz; J C Fuchs
Journal:  Surgery       Date:  1990-06       Impact factor: 3.982

5.  The case for wider use of testing for HIV infection.

Authors:  F S Rhame; D G Maki
Journal:  N Engl J Med       Date:  1989-05-11       Impact factor: 91.245

Review 6.  Transmission of the human immunodeficiency virus.

Authors:  G H Friedland; R S Klein
Journal:  N Engl J Med       Date:  1987-10-29       Impact factor: 91.245

7.  A survey of exposures, practices and recommendations of surgeons in the care of patients with human immunodeficiency virus.

Authors:  D A Mandelbrot; W R Smythe; S A Norman; S C Martin; R M Arnold; G H Talbot; P D Stolley
Journal:  Surg Gynecol Obstet       Date:  1990-08

Review 8.  The acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus (HIV). Health and Public Policy Committee, American College of Physicians; and the Infectious Diseases Society of America.

Authors: 
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

9.  Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus.

Authors:  R Marcus
Journal:  N Engl J Med       Date:  1988-10-27       Impact factor: 91.245

10.  Unrecognized human immunodeficiency virus infection in emergency department patients.

Authors:  G D Kelen; S Fritz; B Qaqish; R Brookmeyer; J L Baker; R L Kline; R M Cuddy; T K Goessel; D Floccare; K A Williams
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.